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1 
INTRODUCTION 
 
Severe Acute Maternal Morbidity (SAMM) is the acronym for the more 
popular term of „near miss‟ cases.  “It is severe life  threatening  obstetric 
complication  necessitating  an  urgent medical  intervention  in order to 
prevent the  likely  death of  the mother”   
 
Maternal  mortality  is the  tip  of the  iceberg, there is a large  base  of  
the severe  acute maternal morbidity, the  identification  &  analysis  of which  
will tell the true  story  of  the  complication. 
 
Worldwide, daily approximately 800 women die every day from 
preventable causes related to pregnancy & delivery. Most of the situations are 
preventable.  About 99% of maternal deaths occur in developing countries. 
 
Analysis of near miss  cases will  help to  assess the  quality of service 
&  will suggest the  areas  where  improvements  are  to  be brought in ; both in 
trained personnel &  in equipment  &  can strengthen our  understanding of the 
disease  progression  that ultimately  saves  the  woman &  there by  empower  
us to prevent  maternal  death. The analysis  of maternal death  has long  been 
used for  the  evaluation  of quality of women‟s  health  care  &  the  level of  
socio economic  development. 
2 
Near Miss appraisal has emerged as the new Yard Stick to assess the 
quality of maternal health care. Maternal   Near Miss defined  as “A Women  
who nearly died  but survived a complication that  occurred during child birth 
or  within 42  days of  termination of pregnancy”1 
 
For every maternal death, there are approximately 100 women with 
severe acute maternal morbidity are referred to as maternal near miss at our 
institution. Compared to maternal death audit, assessment of maternal near 
miss offers several advantages. 
 
SAMM is an apt for the present health providing system
2
. SAMM has  
been  studied  extensively  in  the  recent  past as  a  complement for  maternal  
mortality &  also to evaluate the  quality of  obstetric  care.
3 
 
 In 2009, WHO published near miss  criteria  to provide standardized 
approach to  identify near miss cases in both individual  institution & larger 
health  care  system  would  thus  allow for  the development of interventions to 
improve  maternity  health  care.  While there  has  been  increased  uptake of 
WHO  near  miss criteria  in  developing  nations, most  developed nations  
have  continued to utilise  their own reporting systems.
4 
 
The aim of this study was the application  of the WHO  near miss 
criteria & to  assess its  utility  in  identifying  cases  of  severe  maternal  
morbidity  in our tertiary  hospital  setting. 
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Haemorrhagic Disorders 
Abruption placenta 
Accrete /increta /percreta placenta 
Ectopic pregnancy 
PPH 
Ruptured uterus 
Hypertenisve Disorders 
severe preeclampsia 
Eclampsia 
severe hypertension 
Hypertensive encephalopathy 
HELLP syndrome 
Other systemic disorders 
Endometritis 
Pulmonary edema 
 Respiratory failure 
Seizures 
Sepsis 
Shock 
Thrombocytopenia 
Thyroid  crisis 
Severe managemental indicators 
 Blood  transfusion 
Central venous access 
Hysterectomy 
ICU admission 
Prolonged hospital stay(>7 days) 
Non anesthetic accidents 
Return to operating room 
Surgical intervention 
Potential Life Threatening Complications 
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WHO Maternal near MISS Criteria (SAMM) 
 
 
Clinical criteria 
Acute cyanosis 
Gasping 
Respiratory rate>40 or <6/min 
Shock 
Oliguria non responsive to fluids or diuretics 
Clotting failure 
Loss of consciousness lasting ≥ 12 hrs. 
Loss of consciousness lasting AND absence of pulse/ heart beat 
Stroke 
Uncontrollable fit/total paralysis 
Jaundice in the presence of preeclampsia 
 
Laboratory-based criteria 
Oxygen saturation <90% for ≥60 min 
Pao2/fio2<200 mmhg 
Creatinine≥300µmol/l or 6.0mg/dl 
Ph<7.1 
Lactate>5 
Acute thrombocytopenia 
loss of consciousness  and  the presence of glucose and ketoacids in urine 
5 
Management-based criteria 
Use of continuous vasoactive drugs 
Hysterectomy following infection or haemorrhage 
Transfusion of ≥5 units red cell transfusion 
Intubation and ventilation for ≥60 min not related to anaesthesia 
Dialysis for acute renal failure 
Cardio-pulmonary resuscitation. 
 
6 
AIM AND OBJECTIVES 
 
         The main aim and objectives are: 
o To assess the incidence of near-miss instances  
o To analyze the causes of near miss instances 
o To identify associated factors responsible for near miss  instances  
 
7 
REVIEW OF LITERATURE 
 
 Maternal Mortality Rate is an indicator of maternal health and obstetric 
care. Globally, the maternal mortality ratio dropped from  385 maternal deaths 
per 100000  live births in 1990 to  210 in 2013 to 150 in 2015 with 45% 
reduction.  Most High Income Countries have low maternal death rates 
generally ranging from 3 to 12 per 1 lakh that have consistently decreased in 
the last 24 years. Low and Middle Income countries still bear 99% of the 
burden of the maternal mortality.  A sustainable developmental goal for 2030 is 
to reduce the global MMR to 70 per 100000 live births and for no country to 
exceed two times the ratio.
5,6 
 
The MMR is 912 per 100000 live births  according  to WHO-2012. With 
the fall in MMR in advanced countries, SAMM has been proposed as an 
indicator quality of obstetric care 
 
In 2016, MMR  in India is 130  per 100000 live births, 
MMR  in Tamil Nadu  66 per 100000 live births. 
 
The  improvement of maternal  health has made slow progress in most 
of the countries.
7 
According to WHO (World Health Organization), The 
UNICEF  (United Nation International Children‟s Education Funds),  UNPF 
(United Nation Population Fund), World bank (2014) estimates  globally  
2,89,000 maternal death  occurred in 2018. 
8 
Thus in this situation SAMM /Maternal Near Miss could serve as a 
surrogate for maternal death to evaluate the quality of obstetric care in 
particular health institution. 
 
    A maternal near miss evento or SAMM is currently complication that 
occurred during pregnancy, child birth or within 42 days of termination of 
pregnancy” 8,9,10 
 
Globally more than half of the maternal deaths were due to haemorrhage 
and hypertensive disorders and sepsis common causes of maternal mortality 
varied by regions
10
. Because there was no uniform criteria for identification of 
near miss cases and no standard definition of maternal near miss until 2009 and 
heterogeneous estimate of rates was observed in different published literatures 
around the world.
 11,12,13
   
 
The Ministry of health, taken actions so far include organizing and 
mobilizing the health developmental army at all levels to promote  behavioural  
change,  the distribution of 108 ambulances to all districts and  promotions  of 
free maternity mobile services at different health care levels, the training  of  
human resources  at  primary  health  level and health professionals in health 
facilities, the provision of adequate drugs, medical supplies and equipments.
 14
  
9 
There is a need to assess the magnitude and possible cause that 
contribute to the maternal mortality. However, maternal near miss is a rare 
event.  There is a benefit in including a  large number of cases  for analysis, as 
research  related to maternal near miss is crucial, when examining the quality 
of obstetric care.  
 
In 2009, WHO established  a set of criteria for SAMM  and for near 
miss in order to standardize data and to calculate indicators for comparing 
different settings and identify cases of interest. Severe acute maternal 
morbidity (SAMM) and maternal near miss or events involved in biological 
continuum that goes from the normal healthy situation of pregnancy to 
maternal deaths.
15,16 
 
The identification of cases of maternal near miss  is an alternative  to  
the  investigation of maternal deaths, when assessing the  quality of  obstetric  
care. 
 
Conceptually, maternal near  miss  represent part of  continuum  
between  extremes of  good health &  death.  On this  continuum,  pregnancy, 
labour  or the  puerperium may be perceived as uncomplicated, complicated, 
severely complicated or life threatening  or  fatal.  
 
 Indeed from obstetric condition, the woman  may  recover,  become  
temporarily  or permanently disabled or die. The drawback in designating, 
where woman is  positioned as a  maternal  near  miss on  this  continuum 
10 
lesion  is  the definition of  the threshold  of severity above which morbidity  
qualifies  to  be near miss.   
 
    While this threshold is clear  for  some obstetric  condition or their 
management (for instance, ruptures managed by emergency hysterectomy) or 
severe post partum haemorrhage  requiring massive blood transfusion. It  may 
be uncertain or ambiguous for other condition such as Sepsis. 
 
   Secondly, the threshold above which an adverse obstetric event becomes 
life threatening may be context specific.  This is so because the probability of 
death from such complications depends not only on the women‟s vulnerability 
to succumb to a given complication but also on access to prompt and quality 
care. 
 
The definitions used to identify a maternal near miss have to take the 
local context into consideration and therefore health system factors. 
  
 
 Three approaches have been proposed for definition of maternal near miss.  
1. Utilization of clinical features (sign, symptoms, clinical features such as 
eclampsia, uterine rupture) 
2. Criteria of organ dysfunction 
3. Criteria utilizing clinical management practices (such as admission to 
intensive care). 
 Morbidity data is vital for health planners and policy makers who need 
to know how many women need essential obstetric care.  Morbidity  
11 
data  and case fatality ratios are essential and reliable indication of the 
quality of obstetric care and the efficiency of the health system and  
therefore  can supplement maternal mortality data.   
 
      Maternal Mortality  Ratios are  difficult to use for evaluating  the  success 
of   programme (designing, monitoring &  evaluating  maternal  mortality 
programmes) 
 We  assess  the prevalence/ incidence of maternal near  miss morbidity,  
maternal mortality and case fatality ratio through systemic review of literature.  
 
   The search was  conducted by me based on the medical and social 
science and data bases including pubmed  medline, popline, social science 
scitation index from 2016 to 2018 were searched for studies  on life threatening 
obstetric complication, severe acute maternal morbidity.  
 
The key words used were severe acute maternal morbidity or near miss 
maternal morbidity limited to KAPV Govt. Medical College. I also critically 
reviewed the reference list of these identified articles in an attempt to identify 
more articles.  
 
 We analysed studies which reported information (in pregnancy, child 
birth or puerperium ) on severe maternal morbidity.  
 
Maternal near miss  a concept of paradigsm began in the early 1990‟s in 
reference to women who survived severe acute obstetric complication our 
review attempts to  highlight  studies  that utilizes this concept or paradigsm  
12 
(irrespective of the terminology used to refer to these cases of SAMM who 
would  have died of  pregnancy complications but somehow survived ). 
 
  Since it is very difficult to assess the quality of secondary data, all 
secondary datas was excluded from this analysis. I included all cross sectional, 
descriptive and prospective studies on severe maternal morbidity conducted in 
KAPV, Trichy.  
 
  Mantel conducted a study in 1998 in which all cases fitting the 
definition of maternal near miss were identified the reasons for being classified 
as a near miss were recorded and the primary obstetric factors and any organ 
failure or dysfunction were identified.  The chief reason of such a classification 
was to assist in prevention programmes.
17 
 
   A retrospective study was  conducted at the obstetric unit of olabisi 
onabanjo university teaching hospital sagamu betweek 2002 and 2004, to 
determine the frequency of near miss (SAMM) and  the nature of near miss 
events and comparatively analysed near miss morbidities and the maternal 
death among pregnant  women managed over a 3  year periods.. They 
concluded that the quality care received by this patient was sub optimal. They 
also proposed the development of evidence based protocol and the 
improvement of resource for managing severe morbidities in cases of 
hypertension and heamorrhage. 
13 
 A study conducted in public and private hospitals in Indonesia between 
2003 and 2004 showed a higher prevalence of near miss in the public hospitals 
when compared to private hospitals. About 70% were in a critical state on 
admission at the public hospital suggesting the delay in reaching the hospital.  
 
    A nationwide population based study on SAMM during a 2 year period 
in the Netherlands, found the immigrant women to be at a higher risk and 
substandard care was found in the majority of cases assessed through clinical 
audit. 
  It is crucial to arrive at the uniform criteria by which a near 
miss/SAMM case is identified in order o advance wider use of third concept as 
a tool to investigate and improve the quality of obstetric care and to calculate 
comparable summary estimates across settings and over time. 
 
    WHO has initiated a process in agreeing on a definition and developing 
a uniform a set of identification criteria (clinical criteria, laboratory based 
criteria, management based criteria) for maternal near miss cases aiming to 
facilitate the reviews of these cases for monitoring and improving quality 
obstetric care.
18 
 
An effective program of medical audit will help provide reassurance to 
doctors, patients, and the managers that the best quality of service is being 
achieved, having regard for the resources available.  Many types of audit of 
clinical practices have been developed. 
14 
 One such audit of the quality of maternal care is confidential enquiry 
into maternal deaths. 
 
 The presumption of most of the audit programmes is that by looking at a 
specified case, solutions to inadequacies found will improve not only the 
quality of care of similar cases but also the care of other patients in the 
services. 
 
15 
METHODS AND MATERIALS 
 
Quality of Methods & Data Abstraction 
For the assessment  of  the  study quality, a  structured data collection  
form  from  the  WHO  systematic  review  of  maternal  mortality & morbidity 
was  used. The study quality was assessed by using the following criteria. 
 
1. Description of  study period .  
2. Information  about  population  characteristics. 
3. Information  about setting & context. 
4. Information about eligible & lost subjects. 
 
Definition  of  condition used ( for maternal  morbidity ), forms  of 
reporting data, information  about using special efforts  to  capture all cases  of 
severe morbidity  or maternal  deaths, limitations  of  the  studies & criteria  
used to  address credibility  &  internal validity. Data  on  the  incidence  or  
prevalence of  maternal near  miss  & case fatality  was  extracted. 
 
The prevalence  or  incidence  ratio of  maternal near  miss was 
estimated on  the total number of such  events  divided by  total  number  of  
participants  in  the  particular study. 
 
16 
Study Settings & Periods  
   Because most  critical  maternal cases  are  referred  to our hospital 
known  to provide  better care, the  presence  of  ICU, maternity  ward,  blood 
transfusion series &  facility for  superspeciality. 
 
Study Designs & Methods 
`A  facility  based descriptive study  design was  used to  address  the  
objectives  of  the  current  study. A  descriptive  study  with  nested  
component was conducted  to  identify  pregnant women  who  were  @  risk of 
SAMM  in KAPV Govt  maternity hospital from  October 2016- September 
2018.   
Case identification was prospective & data collection was performed  
concomitantly. The population studied is of low socioeconomic level & the  
vast  majority depends  on the public  health system. This institution is 
responsible for 800- 1000  deliveries per month, is the reference maternity 
hospital  for  low, medium & high risk  cases. 
 
In this  study, we included  all  admitted  patients that  fulfilled the  
current criteria  for  SAMM  according  to WHO  working  group on  maternity  
mortality & morbidity. 
 
Identification of Cases  
All women  admitted  to the  participating  hospital during the  study 
period  for the  treatment  of pregnancy  related complication  (such as ectopic 
pregnancy,  abortion)  having delivered or within  42 days of termination  of 
17 
pregnancy  & who fulfilled at least one  of  the  condition stated  in WHO 
criteria 
8
.  
 
Maternal Near miss Operational Guidelines 
  The clinical findings, investigations, interventions have been put under 
three broad categories,  
 
1.  Pregnancy  specific obstetric  and  medical  disorders. 
2.  Pre-existing disorders aggravated during pregnancy. 
3. Accidental / incidental disorders in pregnancy. 
 
 These  broader  categories  have  further been  segregated  under different 
clinical  situations  like  haemorrhage,  sepsis, hypertension.  
 
   Depending  on  when  the  near miss  occurred, maternal near  miss 
cases were  further  categorized  into  two groups. Women  who  were  assessed 
as  being in critical  condition on  arrival to a  hospital were  classified as  near  
miss before  arrival, However if  the near  miss  occurred during  
hospitalization, it  was  classified  as  near miss after arrival. 
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Need for the Study 
Each year in India, roughly 30 million women experience pregnancy & 
27 million have live births.  For every maternal death, there are close to 100 
women with severe maternal morbidity.  Compared  to  maternal  death  audit,  
assessment  of maternal  near  miss  offers  several advantages.  
SAMM cases continue to have huge impact on the lives of Indian 
women.  Maternal death to near miss ratio & case fatality ratio are the main 
indicators of SAMM. There is a need to identify nearmiss cases to assess the 
quality of health care. 
In Millenium development goal 2000, the goal number 5 was to improve 
the maternal health. It is falling way below our target, as our aim to reduce the 
maternal mortality by 75% by 2015 has not been met.
5 
Survivors  can  be  interviewed,  such  that  such  review  yield useful 
information  on the pathways, that leads  to severe  morbidity &  death. Hence, 
such  assessment  highlights  the quality  of obstetrics  that are received.   
The advantages of “near miss” over death are that near miss are more 
common than maternal deaths, their review is likely to yield useful information 
on the pathway that lead to severe morbidity and death, investigating the care 
received may be less threatening to providers because the women survived and 
one can learn from the women themselves since they can be interviewed about 
the case they received. 
 
 
25 
Sample Size Determination 
The study is designed as a descriptive study. This study would  be 
conducted on the women  who  experienced a  maternal  near miss  event 
during pregnancy, delivery or  the  postpartum period  where identified  
prospectively  admitted at Mahatma Gandhi Memorial Hospital, 
Tiruchirappalli. 
 Data relating to  the most  important variables were  abstracted  from the  
medical record of  the participants using the WHO data abstraction tool, with  
some modification. The datas  were  collected  from the delivery ward, O& G  
ward, ICU  ward. 
For  each  maternal near  miss  case,  the  only one underlying  cause 
was  identified  as  per the WHO  international statistical  classification of 
disease  & related  health  problem (ICD).   
According  to ICD,  the  underlying  cause  is  the  disease  or injury  
which  initiated  the sequence of  events  leading directly to  death.
19
 Because 
the  same classification is  used  for  both maternal death & maternal near miss,  
the classification  used for both maternal  near  miss were the  same  as those 
listed  in  ICD for  maternal mortality.
 20, 21 
However all  possible  contributing causes  were  connected, information 
regarding whether  the  near miss was present  before arrival  or  developed 
during hospitalization  was also  collected in  order  to determine the place, 
where  the near miss  occurred. Data on the total  number of  live births  
26 
occurring  over  one  year  for  our  hospital, were  extracted  from Hospital 
Management Information System (HMIS)of our hospital. 
 
Inclusion Criteria 
A  women presenting with any life  threatening conditions and  
surviving  a  complication that occurred during pregnancy, child birth,  or 
within  42 days of  delivery &  termination of  pregnancy  are  included  in  this 
study. 
1. SAMM identified as per WHO criteria - Those with organ dysfunction  / 
organ  failure. (Clinical criteria,  laboratory  based  criteria, management  based  
criteria). 
 
Exclusion Criteria 
1. Those who  do not give  consent. 
2. SAMM due to non obstetric  causes  such  as  due to  poisoning  & 
trauma. 
3. Those > 42 days of  delivery  or termination of  pregnancy. 
 
Study Design: Descriptive Study 
Study  Place:  K.A.P.V  Govt  Medical College & MGMGH, Trichy  at  
Department  of  Obstetrics  & Gynaecology. 
 Period of study: October  2016 -  September 2018.  
 
27 
Data Processing and Management 
After getting consent the data that were collected using hard copies. 
Following this the data were entered into SPSS software version and were 
opened for final analysis. 
 
Maternal Near Miss Indicators 
1. Maternal  near  miss   
2. Maternal death 
3. Live  birth  
4. Severe  maternal  outcome ratio 
5. Women  with  life  threatening  condition 
6. Maternal  near miss  ratio 
7. Maternal  near  miss  mortality ratio 
8. Mortality  index  : No of  maternal  deaths  divided  by  the  number  of  
women  with life  threatening conditions, expressed  as a  percentage. 
the  higher the  index, is  more  women  with  the  life  threatening  
condition  die (Low quality  of  care),  while  low  index  suggest  better 
quality  of  Health  Care.( MI= MD/ MNM+MD) *100. 
 
Data Analysis 
The total incidence of maternal near miss  in the hospitals involved in 
this study was calculated using  maternal near miss incidence ratio (MNMIR) 
formula. This was calculated by dividing the number of maternal near miss 
28 
cases during the study period (2 years) by the total number of live births during 
the same year, 
                               the number of maternal near miss cases during the  
   study period (2 years)   
MNMIR = 
     the total number of live births during the same year 
 
In addition hospital access indicators, such as the number of women 
with a maternal near miss condition before arrival at the hospital were 
calculated.  Intra hospital care indicators such as number of women with near 
miss who developed condition in the hospital, were also calculated. 
In order to determine the underlying and contributory causes of maternal 
near miss, a descriptive frequency for each cause were calculated separately. 
The causes were categorized into underlying and contributory as per the WHO 
recommendation. Descriptive frequencies of the type of organ dysfunction 
present in maternal near miss cases were also calculated.  
 
Data Quality Assurance 
Data collections made by daily visit to labour ward, O&G AN ward, 
ICU ward, emergency gynaec op to check for the potential cases. The 
standardized data abstraction form developed by WHO was used to abstract 
patient information. Hence, all the above procedures, information‟s contribute 
greatly to obtaining quality data.  
29 
Ethics Statement 
Acceptable ethical statement, were strictly adherent to throughout the 
study process. The study was first approved by the institutional ethical review 
committee  on 2016  October. Adequate explanation about the purpose of the 
study and a letter of support  was given to all concern bodies.  
For studies that were not clinical trials that involved invasive 
procedures, taking verbal consent is the standard requirement of the 
institutional review board. Hence verbal consent was taken to abstract pertinent 
information from the participants‟ record. 
30 
DATA ANALYSIS  
Table: 1 
Educational qualification of SAMM 
Particulars No.of cases Percentage 
Illiterate 3 2.8 
Literate upto 6
th
 std 6 5.71 
Literate from 6
th
-12
th
 std 85 80.9 
Beyond 12
th
 std 11 10.47 
 
In  our study,  the literate from 6
th
-12
th
  was  high  of 85 cases   (80.9 % 
), followed by  beyond  12
th
  around  11 cases ( 10.47%). This table implies 
among 85 cases were literate from 6
th
 to 12
th
 std and they all have poor 
maternal health education & unaware of symptoms occurring in high risk 
during pregnancy. Some have reluctancy towards high risk symptoms.   
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Diagram: 1 
Pie chart - Literacy Rate of SAMM Cases 
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Table: 2 
Age of SAMM 
Particulars No.of cases Percentage 
<20yrs 14 13.3 
21 to 25yrs 35 33.3 
26 to 30yrs 38 36.2 
31 to 35yrs 14 13.3 
36 to 40yrs 4 3.8 
Total 105 100.0 
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Diagram: 2 
Bar chart – Age of SAMM 
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0
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This  table shows,  the majority of  near miss cases  belongs to 26-30 yrs  
around 38 cases ( 36.2%), 2
nd
  most  common age  group ranges from 26-30 yrs  
showing  35 cases (33.3%). 
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Table: 3 
Socio Economic Status of SAMM 
Particulars No.of cases Percentage 
II 3 2.9 
III 62 59.0 
IV 38 36.2 
V 2 1.9 
Total 105 100.0 
 
According to kuppusamy revised scale 2018, socioeconomic class   
describes  
I - Upper  
II- Upper Middle 
III- Middle / Lower middle 
IV -Lower/upper lower 
V- Lower 
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Diagram: 3 
Cylinder chart - Socio Economic Status of SAMM  
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This table explains the frequency of socio economic status. According  
to Kuppusamy revised  scale 2018, majority  of  study  group  belongs  to SES 
III (59%), followed  by  SES IV(38%), SES II( 3%), V (2%)  respectively. 
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Table - 4 
Chi-square test - Comparison between age and their SES status of SAMM 
Age 
SES Statistic
al 
inferenc
e 
II III IV V Total 
n % n % n % n % n % 
<20y
rs 
0 .0% 
1
0 
16.1% 4 10.5% 0 .0% 14 13.3% 
X
2
=15.0
79 df=12 
0.237>0.
05 
Not 
Significa
nt 
21 to 
25yrs 
1 33.3% 
2
0 
32.3% 
1
3 
34.2% 1 50.0% 35 33.3% 
26 to 
30yrs 
0 .0% 
2
1 
33.9% 
1
7 
44.7% 0 .0% 38 36.2% 
31 to 
35yrs 
1 33.3% 9 14.5% 3 7.9% 1 50.0% 14 13.3% 
36 to 
40yrs 
1 33.3% 2 3.2% 1 2.6% 0 .0% 4 3.8% 
Tota
l 
3 
100.0
% 
6
2 
100.0
% 
3
8 
100.0
% 
2 
100.0
% 
10
5 
100.0
% 
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Table – 5 
Descriptive statistics  
 Age GA ICU Stay Total Stay 
N 105 92 105 105 
Missing  0 13 0 0 
Mean 26.11 30.54 11.01 22.63 
Median 26.00 34.00 11.00 20.00 
Std. Deviation 4.583 10.163 6.190 9.241 
Minimum 19 0 4 10 
Maximum 40 38 42 60 
 
 In  this  table, the age  corresponding  to  minimum  of  19  to  the  maximum  
40, showing  mean value  around  26.11, the  standard deviation is  4.58.  The  
total hospital  stay,  minimum  of 10 days  to  the maximum of  60  days., the 
mean value shows  22.63.  In  our  study the ICU stay  ranges  from 4 days to 
42 days, the mean value is 11.     
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Diagram: 4 
Cone chart - Descriptive statistics  
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Table :6 
Causes of SAMM 
Particulars No.of cases Percentage 
GHTN 46 43.8 
Haemorrhage 44 41.9 
Sepsis 4 3.8 
Viral fever 3 2.9 
Anaemia  2 1.9 
RHD 3 2.9 
AFLP 1 1.0 
CPM 1 1.0 
CHD 1 1.0 
Total 105 100.0 
 
In this study, this table contains  the  core content, in which  GHTN  
cases were  the maximum  in  number  around 46  cases,  showing 43.8%. 
Following haemorrhage shows 44 cases, 41.9%.  Next  comes  sepsis 4 cases 
(3.8%), RHD 3 cases (2.9%),viral fever 3 cases(2.9%), anaemia 2 cases (1.9%), 
CHD 1 case ( 1%), AFLP 1  case (1%), central pontine myelinosis  1 case ( 
1%). Hence, GHTN occupies the first major cause of SAMM, followed  by  
haemorrhage  leads to the 2
nd
  place,  sepsis carries  3
rd
 place for  the SAMM 
cases. 
40 
Diagram: 5 
Bar chart – Causes of SAMM 
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Table: 7 
Diagnosis of SAMM 
 
Causes Diagnosis 
No.of 
cases 
Percentage 
1.GHTN 
AP Eclampsia 16 15.2 
Abruptio Placenta 15 14.3 
HELLP 11 10.5 
Pulmonary Edema 8 7.6 
PP Eclampsia 3 2.9 
Total 53 50.47 
2.Haemorrhage 
Atonic PPH 14 13.3 
Bleeding Placenta Previa 11 10.5 
Ruputre Ectopic 12 11.4 
Total 37 35.23 
3.Others 
Sepsis 4 3.8 
Fever 3 2.9 
RHD 3 2.9 
Acyanotic Heart Disease 1 1.0 
AFLP 1 1.0 
Anaemia 2 1.9 
CPM 1 1.0 
Total 15 14.2 
 Grand Total 105 100.0 
 
42 
As  we already discussed  in  the previous  table,  that  the  GHTN  was  
the  leading  cause of  near miss cases, followed by haemorrhage  and  sepsis. 
This table  elaborately, explains  the  frequency & percentage of  GHTN  
induced high risk sequalae causing near miss cases  such as  AP eclampsia, 
Abruption, HELLP, pulmonary edema and  also the  major haemorrhagic  
causes like Atonic PPH, Bleeding placenta previa, Rupture ectopic are depicted 
clearly. 
 
Among  this  GHTN  induced  near miss cases, AP eclampsia  leading 
the  first  place showing frequency of 16 cases& 15.2%,  followed  by  
Abruption  shows  2
nd
 leading  cause that is 15 cases & 14.3%,  3
rd
 cause  was  
HELLP around  11 cases &  10.5%, 4
th
 comes pulmonary edema has 8 cases & 
7.6%, Last was PP eclampsia shows 3 cases & 2.9%.  
 
Haemorrhage plays the  second leading cause for SAMM. Atonic PPH is 
the first major cause for  haemorrhage  showing frequency of 14 cases & 
13.3%, followed by  bleeding placenta  previa  11 cases  & 10.5%, ruptured 
ectopic 12 cases & 11.4% resp., 
 
In  this  study group, sepsis occupies 3
rd
 place showing  4 cases & 3.8%, 
followed by fever 3 cases & 2.9%, RHD has 3 cases & 2.9%, anaemia 2cases 
& 1.9%, acyanotic heart disease 1%,AFLP 1%, CPM  1%.  
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  Diagram: 6 
Diagnosis of SAMM 
 
a. GHTN 
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B. HAEMORRHAGE  
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c. Others 
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 Table: 8 
Oneway ANOVA ‘f’ test difference between causes and their ICU stay 
ICU Stay n Mean S.D Min. Max. 
Statistical 
inference 
AP Eclampsia 16 11.50 8.626 5 42 
F=3.821 
.000<0.05 
Significant 
HELLP 11 9.36 3.009 5 15 
Abruptio Placenta 15 11.60 3.376 6 18 
Pulmonary edema 8 12.38 3.701 7 18 
Atonic PPH 14 8.43 3.155 3 13 
Bleeding Placenta 
Previa 
11 11.64 8.213 5 28 
Ruputre Ectopic 12 8.75 3.596 5 17 
Sepsis 4 10.75 3.862 7 15 
Fever 3 14.67 2.082 13 17 
RHD 3 7.67 1.528 6 9 
Acyanotic Heart 
Disease 
1 14.00 .000 14 14 
AFLP 1 32.00 .000 32 32 
Anaemia 2 12.50 .707 12 13 
CPM 1 38.00 .000 38 38 
PP Eclampsia 3 8.67 4.041 5 13 
Total 105 11.01 6.190 3 42 
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Table :9 
Admitted with Disorder 
Particulars No.of cases Percentage 
Admitted with Severe illness 92 87.6 
Admitted with no disorder and became near miss 9 8.6 
Admitted with disorder and became near miss 4 3.8 
Total 105 100.0 
 
In this study place, the increased frequency of near miss cases was found to 
be admitted with severe  illness showing frequency of  92 cases (87.6%), 
admitted with no disorder and became near miss around 9 cases (86%), 
admitted  with disorder and became  near miss was 4 cases(38%). 
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Table: 10 
Places of Referrals 
 
 
At  KAPV govt. medical college ( study place),  many of  the  near miss 
cases was  referred from PHCs  about  76 cases (72.4%),  from GH 21 cases ( 
20%),  self (6.7%), private hospital 1%. 
Particulars No.of cases Percentage 
GH 21 20.0 
PHC 76 72.4 
PVT 1 1.0 
Self 7 6.7 
Total 105 100.0 
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Diagram: 7 
Cylinder chart - Places of Referrals 
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Table: 11 
Gravidas at SAMM 
 
In this table, 51 cases (48.6%) of  SAMM  cases  were  multi gravida, 41  
cases (39%)  were primi, PN mothers were  13 cases (12.4%). 
 
 
 
  
 
 
Particulars No.of cases Percentage 
Primi 41 39.0 
Multi 51 48.6 
PN 13 12.4 
Total 105 100.0 
51 
 
Diagram: 8 
Pie chart - Gravidas at SAMM 
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Table : 12 
Gestational age of SAMM 
 
According  to this  table,  many of  near miss cases  belongs to both 
second and  third trimester. 33 cases(31.4%) shows 31-35 weeks, another 33 
cases (31.4%)shows 36 -40 wks., 26 t0 30 wks 16 cases(15.2%), < 10 wks 8 
cases(7.6%), 11 to 20 wks 2 cases(1.9%), PN cases 13(12.4%).  From this 
table, around 66 cases were belongs to 31-40 wks.  
 
 
 
 
 
 
Particulars No.of cases Percentage 
<10wks 8 7.6 
11 to 20wks 2 1.9 
26 to 30wks 16 15.2 
31 to 35wks 33 31.4 
36 to 40wks 33 31.4 
PN 13 12.4 
Total 105 100.0 
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Diagram: 9 
Triangle chart - Gestational age of SAMM 
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RESULTS 
During  the  period  of  audit,  there  were  a total  of 18,207deliveries &  
15,202  live  births, 105  near miss cases  & 65  maternal deaths at MGMGH, 
KAPV govt  medical college. Multiparas were more in this study group. The 
percentage of  multigravida was 48.6%,  whereas primi  belongs  to 39%  given  
in  table 11. Majority of  the  patients  (31.4%)  were  in both second & third  
trimester  at near miss events explained in table 12. 
A total  635 potentially  life  threatening  complications  were  identified  
of  which  105 near  miss  cases are  found at MGMGH, Kapv govt medical 
college during  the study period. Maternal near miss  incidence ratio  is  5.7 /  
1000 live births. Maternal near  miss to  mortalty  ratio is 1.6. The mortality  
index  is 38%.  Among  the  cases of  near miss in this study group, 
Hypertensive  is  found to be one of the most  leading  cause, followed by  
haemorrhage, in this study which is clearly  explained in  table 6,7. 
The maternal  near  miss  incidence ratio was  5.7 /1000 live births 
which is very less compared to  other study group. Studies done in  developing  
countries  varies from  5-40/1000 live births. The study conducted at RSRM,  
Stanely shows  nearmiss incidence rate of 12/ 1000 live births. The maternal 
mortality rate in  TN is  66 / lakh  live births  at 2016. 
 Ours  is a tertiary  care referral  centre  covering  three districts in  & 
around  trichy.,  with most  of these  cases  being  refered in an already 
moribund  state. Majority of the near miss  cases belongs to SES III (table 3),  
the literacy rate among the study  group are  from  6
th
 to 12
th 
(table1). The  table 
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1 implies that the frequency of  literacy rate  from 6
th
 to 12
th
 std  shows 85 
cases  and  they all have poor maternal  health education &  unaware of  
symptoms occurring in  high risk  cases during pregnancy. Some have 
reluctancy  towards  high risk symptoms.  Lack of awareness among the  study 
population,  shows increased frequency of 40 cases(38%), delay in referral was 
20 cases (18%),  according to the table 21. Lack of awareness is the major 
associated factors in this study. 
 The delay in referrals due to lack of blood, are also associated  factors 
for  cause  of  morbidity &  mortality. Delayed diagnosis, delayed referals, &  
inadequate  utilization of  resources might  have  been  the cause for  
morbidities & mortalies  in  our  study. Along with  increased  awareness of 
ones  own  health,  health education may  go a long way  in improving  the  
quality of  obstetric  care.  
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Table :13 
Mode of delivery of SAMM 
Particulars No.of cases Percentage 
Emergency Hystrectomy 22 21.0 
Emergency Hysterotomy 3 2.9 
Emergency Laparatomy 11 10.5 
Emergency LSCS 45 42.9 
LN 24 22.9 
TOTAL 105 100 
 
This table  shows  maximum  of  Emergency LSCS  45 cases(42.9%),  
due to  early interventions  , C-section done for the prevention  of  morbidity 
and  mortality among  high risk cases. Due to failed medical management and 
failure in devascularisation surgical procedures, many cases end up in 
Emergency hysterectomy. The frequency in this  study  shows  22 cases of  
Emergency hysterectomy (21%)., Emergency laparatomy was 11 cases 
(10.5%), labour  natural  was 24 cases (22.9%). 
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Diagram: 10 
Cone chart -Mode of delivery of SAMM 
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Table :14 - Cross tabulation between Age of SAMM cases and mode of delivery 
Age 
Mode of Delivery 
Statistical 
inference 
Emergency 
Hystrectomy 
Emergency 
Hysterotomy 
Emergency 
Laparatomy 
Emergency 
LSCS 
LN Total 
n % N % n % n % n % n % 
<20yrs 1 4.5% 1 33.3% 0 .0% 4 8.9% 8 33.3% 14 13.3% 
X
2
=34.809 
Df=16 
.004<0.05 
Significant 
21 to 
25yrs 
9 40.9% 0 .0% 2 18.2% 21 46.7% 3 12.5% 35 33.3% 
26 to 
30yrs 
5 22.7% 2 66.7% 6 54.5% 14 31.1% 11 45.8% 38 36.2% 
31 to 
35yrs 
5 22.7% 0 .0% 3 27.3% 6 13.3% 0 .0% 14 13.3% 
36 to 
40yrs 
2 9.1% 0 .0% 0 .0% 0 .0% 2 8.3% 4 3.8% 
Total 22 100.0% 3 100.0% 11 100.0% 45 100.0% 24 100.0% 105 100.0%  
Since, the p value shows < 0.05,  the study  is significant. 
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Table: 15 
Blood Transfusion 
Particulars No.of cases Percentage 
No 18 17.1 
Yes 87 82.9 
Total 105 100.0 
 
Diagram: 11 
Pie chart - Blood Transfusion 
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Table: 16 
Intervention done at SAMM 
Particulars No. of cases Percentage 
MV & Blood Products 25 23.8 
MV 26 24.8 
Higher Antibiotic 5 4.8 
Platelets 3 2.9 
Blood & Blood Products 46 43.8 
Total 105 100.0 
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Diagram: 12 
Triangle chart - Intervention done at SAMM 
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Table: 17 
Blood and Blood products 
Particulars No.of cases Percentage 
Packed Cell 18 17.1 
Blood, FFP Cryo 20 19.04 
Blood, FFP, Platelets 15 14.2 
FFP 2 1.9 
FFP/ Platelets 8 7.6 
Whole blood 31 29 
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Diagram: 13 
Cylinder chart - Blood and Blood products  
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Table: 18 
Means of Transport 
 
 
Particulars No.of cases Percentage 
108 ambulance 96 91.4 
Public Transport 5 4.76 
Personal  Vehicle 2 1.9 
Others 2 1.9 
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Diagram: 14 
Bar chart - Means of Transport 
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Table: 19 
Cases of SAMM 
Particulars No.of cases Percentage 
Before Arrival 96 91.42 
During Hospitalization 9 8.57 
 
Diagram: 15 
Pie chart - Cases of SAMM 
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Table: 20 
Organs involved in SAMM 
Particulars No.of cases Percentage 
Brain 30 28.6 
Heart 3 2.9 
Kidney 2 1.9 
LIver 9 8.6 
Lungs 9 8.6 
MODS 2 1.9 
Coagulation 21 20.0 
Uterus, Coagulation 27 25.7 
Spleen 2 1.9 
Total 105 100.0 
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Diagram: 16 
Triangle chart – Organs involved in SAMM 
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Table: 21 
Additional Factors 
Particulars Frequency Percentage 
Delay in Referral 20 19.04 
Refusal of treatment or admission 10 9.52 
Lack of Awareness 40 38.09 
Lack of Blood products at referral 35 33.33 
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Diagram: 17 
Angle chart – Additional Factors 
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   Incidence of SAMM, during the study period, a total of 105 maternal near miss 
cases and 15,202 live births were reported in our hospital which produced total maternal 
near miss ratio of 5.7per 1000 live births. Many of the study population belong to low 
socio economic state as per table 3. 
  The reported incidence of maternal near miss varies in different studies and range 
from (<1to82 per thousand live births). For some instances, the rate ranged between 
0.14% &0.75% in some high income countries and it ranged between 1.5% to 7.7% in 
some  middle  income countries. World wide hypertensive disease of pregnancy, obstetric 
hemorrhage and sepsis have been major causes of maternal near miss.
23,24 
 
Characteristics of women with SAMM: 
 The majority of 93.3% of SAMM cases were referred from other health facilities 
from which 91.4% 108 ambulance was used by most of the mothers as a means of 
transport to the study hospital at MGMGH as per (Table-18).A significant number 91.4% 
of near misses occurred before arrival at the participating hospitals. Only 8.57% of cases 
became near miss during hospitalization. (table 19). 
 
Anaemia plays a major underlying contributing cause of maternal nearmiss cases. 
It is due to the major fact for the occurrence of  abruption, atonicity  etc., This finding is 
also comparable with middle income countries. Such as Iraq ,Nepal, other states of India 
and Pakistan. 
26,27,28
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Organ Dysfunction in SAMM Cases: 
   The number of major organ dysfunction seen in majority of SAMM cases were 
neurological at 30 cases (28.6%), uterus &coagulation at 25.7% & hematological at 
21(20%), respiratory dysfunction at 9 cases (8.6%), cardiovascular at 3 cases (2.9%), 
hepatic dysfunction 8.6%,and renal dysfunction, were the least reported organ 
dysfunction in our audited  SAMM cases as 1% (table 20). 
 
Underlying and Contributory Causes of SAMM: 
 The underlying cause for the majority of near miss cases were hypertensive 
disorder in total  46 cases(43.8%),including AP eclampsia 16 cases ( 15.2%) and, 
Abruptio placenta 15 cases(14.3%), HELLP 11 cases (10.5%), acute  pulmonary  edema 
8 cases(7.6%),PP eclampsia 3 cases(2.9%), followed by obstetric haemorrhage 
44(41.9%)followed by sepsis 4(3.8%).,(table 5,6) 
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DISCUSSION 
 
During this study period, the SAMM incidence was 5.7 per 1000 live births in our 
study hospital. we used newly developed WHO criteria which are very stringent and 
would identify only critical cases.  However previous studies used disease based criteria 
which are less stringent than the WHO criteria. 
From our  attempts  to  harmonize  the definition used  in far  studies  available, 
the  incidence  or prevalence  ratio of  maternal near  miss ranges from  1.1 -  10.1 %  & 
case  fatality ratio indicating wide variation in reported magnitude of the problem. In  our  
study, maternal  near  miss  incidence  ratio  belongs  to  5.7 per  thousand  live births. 
Case fatality ratio is  6%. 
For studies that includes clinical signs & symptoms, hypertensive disorders, 
haemorrhage, sepsis were the  commonest definition used.  The percentage  of HT 
disorder  43.8%,  haemorrhage (41.9%),sepsis 4%  resp., according to this study 
explained in the (table 6) 
For  studies,  that  employed  the management based  criteria,  for defining  a  
maternal  near miss, emergency  hysterectomy & administration to  intensive care units, 
where  the commonest  procedures  employed. According  to  this  study, emergency 
hysterectomy 21%,  emergency hysterotomy  3%,  emergency laparotomy  10.5%,  
emergency lscs 42.9%, labour  natural,  spontaneous expulsion  22.9%  rep.,other  
management based criteria  includes emergency  postpartum hysterectomy & prolonged  
hospitalization for  more than  four  days. 
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 In this  criteria, indicators  of severity of  blood loss  such as hypo volumeia  requires 
massive blood transfusion  given in table 16, 17, severe anaemia  with  hypotension  ( 
requiring intensive resustitation)  are used  as proxy  indicators for maternal  near miss. 
This is dependent on  the fact that utilization of  high dependency obstetric  care  
facilities  or massive  or  prolonged resuscitation indicates a  critically  ill  patient 
whether in  pregnancy, labour or postpartum. 
  In this  study, total blood transfusion  requires 64.7%,usage of  whole  blood  29%, 
packed  cells 17.1%, FFP & blood-19.04%,  FFP& Platelets -7.6%,  FFP- 1.9%  as  per 
table 16,17. 
The justification  of  the  organ  system  dysfunction based  criteria,  proposed  by 
mantel  et  al is that women  with organ  /  system  dysfunction  are  likely  to occur,  
unless  adequate  &  prompt  care is  provided .for instances, obstetric haemorrhage  
constitutes a  maternal  near miss  through vascular ( hypovolumeia),  renal ( oliguria),  
coagulation  dysfunction. In this study, the organ dysfunction explained previously ,given 
in table 20. 
The  majority of  maternal  near  miss  cases  have already  occurred  on  the 
women‟s  arrival at the  participating hospitals,  a  finding which is in  line with  studies  
from  most developing  countries. For example in Bolivia, Mozambique, Somalia were 
74%,70%,74.2% of near miss cases resp., were in a critical state arrival at the health 
facilities, implying the need to focus on pre  hospital barriers
30,31
,.However,  near miss  
cases  that  develop  during  hospitalization  can help  to  measure  the quality  of  
obstetric  care  provided within  health  facilities. In Iran for example, suboptimal 
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obstetric care was found in 75% of near miss cases
32.
 The occurrence of maternal near 
miss after receiving suboptimal care following C-section has also needs reported 
elsewhere.
33 
 
SAMM study has many strength. The study  is  the  first of  its kind  in  ETHOPIA 
to  document  the  incidence  &  causes  of maternal near miss  using  the newly 
developed WHO  case  identification  criteria. Prospective case identification was used 
for a consecutive period of two year.  The  use  of  a standardized  WHO data  abstraction 
tool  to  abstract  data was  also one of  the  strength of the  study,  which  might  also 
have  had  its  own  implication for  the  quality of  the  study.
34 
 
 However, our study had certain limitations.  The  follow up time  used  by  the  
WHO  to define maternal  near miss  has duration  of  42  days postpartum.  However,  
because of  logistic & feasibility  concern, our  follow up  time was limited  to  only  the  
length  of  hospital  stay. 
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CONCLUSION 
 
  The  study  demonstrated  a  lower  SAMM incidence  ratio  compared  to  
previous  country level  studies. Underlying & contributory causes of maternal near miss 
are still prevalent. Evidence  based  interventions designed  to optimize the  intrapartum 
management of  life  threatening obstetric complications, specially  hypertensive  
disorders &  obstetric  haemorrhage,  could reduce the  occurrence  of maternal near miss 
problems  during hospitalization.  
 
The majority of near miss cases happened before the women‟s arrival at the 
participating hospitals, which underscores the importance of eliminating the pre hospitals, 
barriers.  Hence, it is  necessary  to  create  awareness  among  the  antenatal mothers and 
their  relatives too, about  the  preexisting signs & symptoms  of hypertensive  disorders 
through  area VHN,SHN at  primary  health centre level itself., Hence, it is necessary  to 
create awareness  among the population, about  the health  education and importance of 
health  during pregnancy,  life style modifications, food intakes during antenatal period, 
via  dramas, speech at AN clinic, videos, multimedia, etc., 
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1 2 3 1 2 3
1 NAGAMMAL 25 III 41924 PRIMI 38W 6/10/2016 NO y y
TACHY,HTN,EX
T CREPTS GHTN,PE MV,INJ.LASIX NO PHC
EME 
HYSTRECTOMY LUNGS 7 17
2 KALIYAMMAL 40 IV 46460 MULTI 32W 27/10/16 NO Y
TACHY,HTN,CO
NVULSIONS AP ECLAMPSIA ,MV,INJ.Mgso4 NO GH LN BRAIN 12 19
3 KANAGAMMAL 20 III 49608 PRIMI 28W 11/7/2016 NO Y
TACHY,JAUNDI
CE, HELLP,ABRUPTION  III BLD& BLD PRODUCTS Y PHC EMER LSCS LIVER 18 32
4 SARANYA 24 III 55423 PRIMI 38 14/9/16 NO Y
Colu
mn1
TACHY,HTN,EX
T CREPTS GHTN,PE NO NO PHC EMER LSCS LUNGS 8 25
5 ANGALESHWARI 28 IV 55765 G3P2L2 30 24/9/16 NO Y
TACHY,PALLOR
, ABRUPTION GRADE III BLD& BLD PRODUCTS Y PHC EMER LSCS 14 34
6 RATHIKA 29 III 53998 PRIMI 36 16/9/16 YES Y FEVER,TACHY
POST SURGICAL 
SEPSIS ,HIGHER ANTIBIOTICS N SELF EMER LSCS KIDNEY 15 37
7 RAMU 31 III 64063 P1L1 PN 25/10/16 YES Y FEVER,TACHY
POST SURGICAL 
SEPSIS
HIGHER            
ANTIBIOTIC N PVT EMER LSCS KIDNEY 7 14
8 CHITRA 33 IV 70545 P2L2 PN 29/11/16 NO Y
PALLOR,TACHY
,HYPO ATONIC  PPH BLD & BLD PRODUCTS Y GH
EMER 
HYSTRECTOMY 12 16
9 RADHIKA 30 III 38512 G3P2L2 38 18/12/16 NO Y
TACHY,HYPO,E
XTENCREPTS GHTN,PE,
MV,BLD,CARDIOTONIC
S Y PHC EMER LSCS LUNGS 18 30
10 KOKILA 20 IV 38710 PRIMI 26 27/12/16 NO Y
TACHY,HYPO,P
ALLOR
CENTRAL  PLACENTA 
PREVIA
MV,BLD& BLD 
PRODUCTS Y PHC
EMER 
HYSTEROTOMY 6 15
11 SARANYA 20 III 73876 P2L2 PN 17/12/16 NO Y
TACHY,HYPO,P
ALLOR 2    PPH
MV,BLD & BLD 
PRODUCTS Y PHC
LN/ EMER   
HYSTRECTOMY 12 25
12 SANGEETHA 20 III 75228 P1L1 PN 23/12/16 NO Y
DYSPNOEIC,BR
ADY
ACYANOTIC HEART 
DISEASE MV,CARDIOTONICS N SELF LN HEART 14 22
13 MAHESH 19 III 75235 PRIMI 36 27/12/16 NO Y
TACHY,  
GHTN,CONVUL
SIONS AP ECLAMPSIA MV N PHC EMER LSCS BRAIN 8 28
14 MADHUMALAR 21 IV 75663 PRIMI 36 6/12/2016 NO Y
GHTN,UNCONS
CIOUS GHTN,CVT MV N PHC EMER  LSCS BRAIN 42 60
15 ELAVARASAN 28 III 53421 G2P1L1 30 28/1/17 NO Y
TACHY,HYPO,P
ALLOR
CENTRAL 
PLACENTAPREVIA BLD& BLD PRODUCTS Y GH
EMER 
HYSTERECTOMY 6 17
16 SIVASANGARI 23 III 33821 PRIMI 32 13/1/17 NO Y
DYSPNOEIC,BR
ADY ANAEMIA, CCF BLD& BLD PRODUCTS Y PHC EMER LSCS
SPLEEN,   
HEART 13 28
17 SIVASUDHA 24 IV 62711 PRIMI 34 2/1/2017 NO Y
TACHY,GHTN,T
HROMBOCYTPE
NIA
SEVERE 
PREECLAMPSIA,HELLP
,PALLOR
MV, BLD&  BLD 
PRODUCTS Y PHC EMER LSCS,
BRAIN,LIVE
R 9 30
18 NISHANTHINI 22 V 45012 P2L2 PN 24/1/17 NO Y
TACHY,HYPO,T
HROMBOCYTOP
ENIA
SEVERE 
PREECLAMPSIA,HELLP
,ATONIC PPH ,MV,BLD, INJ.MgSO4 Y PHC
EMERGENCY 
LAPAROTOMY
BRAIN,LIVE
R 15 29
19 PREMADEVI 22 IV 9612 PRIMI 36 5/1/2017 NO Y
CONVULSION,T
ACHY,GHTN AP ECLAMPSIA MV,BLOOD,INJ.MgSO4 Y PHC EMERGENCY LSCS BRAIN 12 23
20 KATHIJABEEVI 29 III 11237 G3P2L2 38 5/1/2017 NO Y
GHTN,UNCONS
CIOUS
,SEVERE 
PREECLAMPSIA,HELLP PLATELETS,INJ.MgSO4 Y PHC
SPONTANEOUS 
EXPULSION
LIVER,BRAI
N 10 30
21 MAHESHWARI 28 IV 5381 G3A2 _ 29/1/2017 NO Y
PALLOR,TACHY
,HYPO RUPTURE ECTOPIC BLD& BLD PRODUCTS Y GH
EMER 
LAPROTOMY 8 20
22 PANCHAVARNAM 23 III 7729 PRIMI 34 9/2/2017 NO Y
PALLOR,TACHY
,HYPO ABRUPTION  GRADE III BLD& BLD PRODUCTS Y PHC EMERGENCY LSCS 12 34
23 GAYATHRI 29 IV 6229 PRIMI 32 30/1/2017 NO Y
UNCONSCIOUS,
GHTN,THROMB
OCYTOPENIA HELLP,ABRUPTION  III MV,BLD Y GH EMERGENCY L LIVER 14 30
24 MURUGESHWARI 26 III 13596 G4A3 28 7/3/2017 YES Y
TACHY,HYPO,P
ALLOR PLACENTA  PREVIA MV, BLD Y PHC
EMER 
HYSTEROTOMY 7 21
25 MAHALAKSHMI 31 III 15281 PRIMI _ 14/3/2017 NO Y
TACHY,HYPO,P
ALLOR RUPTURED ECTOPIC BLD Y self
EMER 
LAPARATOMY 6 24
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GHTN
GHTN
HAEMORHAGE
GHTN
HAEMORRHAGE
HAEMORRHAGE
CHD
GHTN
GHTN
HAEMORRHAGE
SEPSIS
SEPSIS
HAEMORRHAGE
GHTN
GHTN
HAEMORRHAGE
HAEMORRHAGE
GHTN,HAEMORRH
AGE
GHTN
HAEMORRHAGE
ANAEMIA
GHTN
GHTN
HAEMORRHAGE
HAEMORRHAGE
26 PUSHPARANI 36 III 17793
G5P1L1
A3 30 21/3/2017 NO Y
GHTN,TACHY,P
ALLOR
ABRUPTION GRADE III 
&DIC
MV, BLD& BLD 
PRODUCTS Y PHC
EMER SUBTOTAL 
HYSTRECTOMY MODS 6 17
27 MAHALAKSHMI 22 IV 20604 G2P1L0 28 7/4/2017 NO Y TACHY,HYPO PLACENTA  INCRETA MV,IONOTROPICS,BLD Y PHC
EMER 
HYSTRECTOMY 24 32
28 DHANALAKSHMI 31 III 28397 G3P2L2 30 14/5/2017 NO Y
TACHY,HYPO,P
ALLOR RUPTURE UTERUS BLD,BLD PRODUCTS Y PHC
EMER 
LAPARATOMY 7 15
29 JEYASUTHA 29 III 88410 PRIMI 30 22/6/17 NO Y
FEVER,TACHY,I
CTERIC SEPSIS HIGHER  ANTIBIOTIC Y GH LN MODS 13 30
30 KANMANI 29 IV 37083 G3P2L2 37 17/6/2017 NO Y TACHY,HYPO ATONIC  PPH
MV,BLD& BLD 
PRODUCTS Y PHC
EMER 
HYSTERECTOMY 6 16
31 HARITHA 27 III 36859 P2L2 PN 16/6/2017 NO Y TACHY,HYPO 2 PPH
MV,BLD& BLD 
PRODUCTS Y GH
EMER 
HYSTRECTOMY 12 22
32 OCHAMMAL 32 IV 43481 G3P2L2 36 13/7/2017 NO Y
TACHY,HYPO 
,PALLOR PLACENTA ACRETA BLD&BLD PRODUCTS Y PHC
EMER TOTAL 
HYSTRECTOMY 7 14
33 VAITHEGI 26 III 43818 G3P2L2 34 14/7/2017 NO Y
GHTN,THROMB
OCYTOPENIA GHTN, PARTIAL HELLP BLD & BLD PRODUCTS Y PHC LN
BRAIN,LIVE
R 11 30
34 MUTHUMEGALA 21 II 47793 PRIMI 36 30/7/20`7 NO Y
GNTN,THROMB
OCYTOPENIA APECLAMPSIA,HELLP BLD&BLD PRODUCTS Y PHC EMERG LSCS
BRAIN,LIVE
R 13 28
35
RABAYATHUL 
BASRIYA 24 III 47290 G2P1L1 38 28/7/2017 NO Y
BRADY,THREA
DY PULSE
ABRUPTION 
III/HAEMORRHAGIC 
SHOCK BLD&& BLD PRODUCTS Y PHC
EMER  
HYSTERECTOMY 14 33
36 kowsalya 20 IV 40993 PRIMI 32 20/10/2017 NO Y
GHTN,UNCONS
CIOUS AP ECLAMPSIA
MV, BLD& BLD 
PRODUCTS Y PHC LN, BRAIN 6 15
37 DEVI 25 III 45054 PRIMI 32 21/7/2017 NO Y
GHTN,UNCONS
CIOUS AP ECLAMPSIA
MV,BLD& BLD 
PRODUCTS Y PHC EMER LSCS BRAIN 12 18
38 MANIMEGALAI 27 III 47713 PRIMI 34 30/7/2017 NO Y
GHTN,HELLP,TH
ROMBOCYTOPE
NIA ACUTE PE ,HELLP
MV,BLD& BLD 
PRODUCTS Y GH EMER LSCS
LIVER,LUNG
S 16 23
39 SHANTHI 29 IV 41008 G2P1L1 32 3/7/2017 NO Y
SEVERE 
PREECLAMPSIA
PE,PULMONARY 
EMBOLI MV Y PHC EMERGENCY LSCS
HEART,LUN
GS 11 19
40 AMUTHA 34 III 49520 PRIMI 36 6/8/2017 NO Y
GHTN,ACUTE 
PE ACUTE   PE ,PPCM MV Y PHC EMER LSCS
HEART,LUN
G 13 25
41 TAMILAZHAGI 27 IV 51882 P1L1 PN 15/8/2017 NO Y GHTN,FEVER PUERPERAL SEPSIS
MV,HIGHER 
ANTIBIOTICS Y GH LN 8 23
42 SURYA 20 III 78441 PRIMI 38 12/8/2017 NO Y
DYSPNOEIC,TA
CHY
RHD/ SEVERE  
MS/MOD MR/ MOD  
PHTN
MV,DIGITALISATION,C
ARDIOTONICS NO PHC EMER LSCS
HEART,LUN
GS 8 20
43 NOORESHWARI 26 IV 76242 G2P1L1 26 3/11/2017 NO Y
FEVER,TACHY,
COMA DENGUE FEVER MV Y PHC
SPONTANEOUS 
EXPULSION LIVER 14 38
44 SARANYA 25 III 86418
G3P1L1
A1 38 9/12/2017 NO Y TACHY,BRADY ATONIC  PPH
MV,BLD& BLD 
PRODUCTS Y GH
EMER 
HYSTRECTOMY 9 16
45 MAHESHWARI 28 IV 58121
RUPTUR
ED 
ECTOPI
C 0 29/1/17 NO Y TACHY,BRADY RUPTURE ECTOPIC BLD,BLD PRODUCTS Y PHC
EMERG 
LAPAROTOMY 13 24
46 LALITHA 28 III 88441
G4P3L2
A1 36 13/2/17 NO Y GHTN
,SEVERE 
PREECLAMPSIA,HELLP BLD,BLD PRODUCTS Y PHC
ASSISSTED 
BREECH
BRAIN,LIVE
R 5 12
47 ROSELINE METAALFA 21 III 62636 G2A1 34 27/3/17 NO Y
SEVERE 
PREECLAMPSIA
SEVERE 
ECLAMPSIA,HELLP,DI
VC BLD,BLD PRODUCTS Y GH
EMER 
HYSTRECTOMY
BRAIN,LIVE
R 13 18
48 SANGEETHA 28 III 26338 G2P1L1 36 6/5/2017 NO Y
TACHY,DYSPNO
EIC RUPTURE UTERUS BLD Y GH
EMER RPT 
LSCS,UTERINE 
RENT CLOSURE 11 20
49 GAYATHRI 20 III 21416 PRIMI 20 10/4/2017 NO Y
TACHY,DYSPNO
EIC
SEVERE 
PREECLAMPSIAACUTE 
PE , BLD,MV Y SELF
SPONTANEOUS 
EXPULSION
BRAIN,LUN
GS 13 16
50 SARANYA 28 IV 62875 GP1L1 28 13/4/17 NO Y
GHTN,DYSPNEO
IC EMER LSCS BLD,BLD PRODUCTS Y PHC EMER LSCS 11 17
51 SARASU 19 III 35707 PRIMI 34 12/6/2017 NO Y
GHTN,CONVUL
SION GHTN,AP ECLAMPSIA BLD,BLD PRODUCTS Y GH EMER LSCS BRAIN 9 16
52 PRIYA 26 IV 34821 A2 17/6/17 NO Y
TACHY,HYPO,P
ALLOR RUPTURED ECTOPIC BLD,BLD PRODUCTS Y PHC
EMER 
LAPRATOMY 7 13
53 SHAHITHA 24 III 43268 G2P1L1 38 12/7/2017 NO Y TACHY,HYPO ATONIC PPH ,BLD BLD PRODUCTS Y PHC
EMER 
HYSTRECTOMY 6 13
SEPSIS
HAEMORRHAGE
HAEMORRHAGE
HAEMORRHAGE
GHTN
GHTN,HAEMORRH
AGE
HAEMORRHAGE
HAEMORRHAGE
GHTN
GHTN
SEPSIS
RHD
VIRAL FEVER
GHTN
HAEMORRHAGE
GHTN
GHTN
GHTN
GHTN
GHTN
GHTN
HAEMORRHAGE
HAEMORRHAGE
HAEMORRHAGE
HAEMORRHAGE
GHTN
GHTN
HAEMORRHAGE
54
RUBIYATHAL 
BARBRIYA 25 III 47290 G2P1L1 38 28/7/17 NO Y
TACHY,HYPO,P
ALLOR ABRUPTION GRADE III BLD,BLD PRODUCTS Y PHC
EMER 
HYSTRECTOMY 13 20
55 MEESAMANI 27 III 44877 G2P1L1 36 28/7/17 NO Y TACHY,HYPO ABRUPTION GRADE III BLD,BLD PRODUCTS Y PHC EMER LSCSC 14 21
56 BABY 25 IV 50050 G3P2L2 32 8/8/2017 NO Y
GHTN, SEVERE 
PREECLAMPSIA,
HELLP IMMINENT ECLAMPSIA
INJ.MgSO4,BLD&BLD 
PRODUCTS NO PHC EMER LSCS BRAIN 8 14
57 CHITRA 35 III 51214
G4P2L2
A1 34 12/8/2017 NO Y TACHY,HYPO ABRUPTIO PLACENTA BLD&BLD PRODUCTS Y GH EMER LSCS 9 13
58 JOTHI 28 III 56712 G2P1L1 30 4/9/2017 NO Y
HYPO,THROMB
OCYTOPENIA
SEVERE 
PREECLAMPSIA,HELLP BLD& BLD PRODUCTS Y PHC EMER LSCS
BRAIN,LIVE
R 7 19
59 SHARMILA 24 IV 50899 G3P1L1 36 11/8/2017 NO Y HYPO,TACHY PLACENTA ACCRETA BLD& BLD PRODUCTS Y PHC EMER  LSCS 8 15
60 SELVI 22 III 65112 G3P1L1 2/10/2017 NO Y HYPO,TACHY RUPTURE ECTOPIC BLD&BLD PRODUCTS Y PHC
EMER 
LAPARATOMY 5 13
61 PRIYA 20 IV 72468 PN PN 4/10/2017 NO Y FEVER, CREPTS DENGUE FEVER Y PHC PN LIVER 13 22
62 NATHIYA 23 III 72027 G2PL1 30 23/10/17 NO Y HYPO,TACHY ABRUPTION GRADE III BLD& BLD PRODUCTS Y GH EMER LSCS 11 19
63 GOMATHI 25 IV 79656 PRIMI 28 23/11/17 NO Y
DYSPNOEIC,TA
C,GHTN
RHD/ SEVERE  
MS/MOD MR/ MOD  
PHTN
MV,DIGITALISATION,C
ARDIOTONICS Y SELF
SPONTANEOUS 
EXPULSION
HEART,LUN
G 9 22
64 ANITHA 27 IV 77557 G2P1L1 32 7/11/2017 NO Y TACHY,HYPO ABRUPTION  GRADE III BLD&BLD PRODUCTS Y PHC EMER LSCS 12 35
65 JELMIA BANU 29 III 76781 G2P1L1 5/11/2017 NO Y TACHY,HYPO RUPTURED ECTOPIC BLD& BLD PRODUCTS Y PHC
EMER 
LAPARATOMY 17 23
66 FARSHITHA 24 IV 78983 G3P2L2 34 12/11/2017 NO Y TACHY,HYPO PLACENTA PREVIA II BLD& BLD PRODUCTS Y PHC
EMERGENCY  
LSCS 18 40
67 RATHA 23 III 76791 PRIMI 36 5/11/2017 NO Y TACHY, HYPO ATONIC  PPH BLD& BLD PRODUCTS Y PHC EMER LSCS 7 14
68 RAMANA 24 III 67974 PRIMI 34 14/11/17 NO Y TACHY,HYPO
BLEEDING PLACENTA 
PREVIA BLD& BLD PRODUCTS Y PHC EMER LSCS 14 33
69 PASUPATHI 23 III 79762 PRIMI 33 14/11/17 NO Y
GHTN,THROMB
OCYTOPENIA
IMMINENTECLAMPSIA,
HELLP BLD& BLD PRODUCTS Y PHC EMER LSCS
BRAIN,LIVE
R 8 15
70 SASIKALA 30 IV 85053 PRIMI 34 4/12/2017 NO Y
GHTN,CONVUL
SION AP ECLAMPSIA BLD & BLD PRODUCTS Y PHC EMER LSCS BRAIN 7 14
71 MARIYA ARTHY 27 III 64167 PRIMI 36 3/12/2017 NO Y
DYSPNOEA,TAC
HY SEVERE MS/ MR MV, N PHC LN HEART 6 13
72 MEENA 24 IV 85446 G3P2L2 34 6/12/2017 NO Y TACHY, HYPO PLACENTA PREVIA 
MV,BLD& BLD 
PRODUCTS Y PHC EMER LSCS 5 14
73 AKILA 28 III 85996 G2P1L1 7/12/2017 NO Y TACHY,HYPO RUPUTRE ECTOPIC BLD& BLD PRODUCTS Y PHC
EMER 
LAPARATOMY 11 21
74 SARANYA 25 III 86418
G3P1L1
A1 34 9/12/2017 NO Y TACHY,HYPO ATONIC  PPH
MV,BLD& BLD 
PRODUCTS Y PHC
EMER 
HYSTRECTOMY 5 16
HAEMORRHAGE
HAEMORRHAGE
VIRAL FEVER
HAEMORRHAGE
RHD
HAEMORRHAGE
HAEMORRHAGE
GHTN
HAEMORRHAGE
GHTN
GHTN
GHTN
RHD
HAEMORRHAGE
HAEMORRHAGE
HAEMORRHAGE
HAEMORRHAGE
HAEMORRHAGE
HAEMORRHAGE
HAEMORRHAGE
HAEMORRHAGE
75 VEERALAKSHMI 22 IV 88643 G2P1L1 32 18/12/17 NO Y
GHTN,THROMB
OCYTOPENIA HELLP, GHTN PLATELETS Y PHC EMER LSCS LIVER 6 13
76 VEMBU 32 III 182301
G3P1L1
A1 27/3/17 NO Y TACHY,HYPO RUPTURED ECTOPIC BLD& BLD PRODUCTS Y PHC
EMER 
LAPARATOMY 8 17
77 TAMILILLAKIYA 27 III 25402 PRIMI 32 22/5/2017 NO Y
GHTN,TACHY,P
ALLOR ABRUPTION GRADE III BLD& BLD PRODUCTS Y PHC
EMER 
HYSTEROTOMY 7 20
78 NALLAMMAL 21 III 34821 PRIMI 34 8/6/2017 NO Y TACHY,HYPO PLACENTA  PREVIA BLD& BLD PRODUCTS Y SELF EMER LSCS 5 19
79 SELVI 26 IV 71140 G2P1L1 34 20/10/17 NO Y TACHY,HYPO ABRUPTIO PLACENTA BLD& BLD PRODUCTS Y GH EMER LSCS 6 16
80 VENNILA 26 IV 71890 PRIMI 36 22/10/17 NO Y
GHTN,TACHY,U
NCONSICIOUS AP ECLAMPSIA MV,INJ MgSO4 Y PHC EMER LSCS BRAIN 13 29
81 MERLIN ELIZABETH 19 III 2265 PRIMI 18 10/1/2018 NO Y
UNCONSCIOUS,
HYPO
CENTRAL PONTINE 
MYELINOSIS
MV,FLUID 
MANAGEMENT Y GH
SPONTANEOUS 
EXPULSION BRAIN 38 56
82 RAJESHWARI 29 III 9303 G2P1L0 36 11/1/2018 NO Y
HYPO,TACHY,P
ALLOR RUPTURE UTERUS
MV, BLD& BLD 
PRODUCTS Y PHC
EMER 
HYSTRECTOMY 5 16
83 HEMALATHA 31 II 2686 G7P4L4 36 12/1/2018 NO Y
HYPO,TACHY,P
ALLOR ATONIC  PPH
MV, BLD& BLD 
PRODUCTS Y PHC
EMER 
HYSTRECTOMY 7 18
84 THENMOZHI 20 III 9040 PRIMI 34 25/12/17 NO Y HYPO, ICTERIC AFLP
MV,BLD& BLD 
PRODUCTS Y GH LN LIVER 32 44
85 SASIKALA 28 IV 5518 PRIMI 36 25/1/18 NO Y
HYPO,TACHY,P
ALLOR PLACENTA PREVIA
MV,BLD& BLD 
PRODUCTS Y PHC OUTLET FORCEPS 28 40
86 MEENA 20 III 1561 PRIMI 38 12/3/2018 NO Y
HYPO,TACHY,T
HROMBOCYTOP
ENIA VIRAL FEVER PLATELETS Y PHC LN
LIVER,SPLE
EN 17 46
87 THANGAMANI 39 II 1727 P4L4 PN 19/3/18 NO Y
DYSPNOEIC,TA
CHY,PALLOR ANAEMIA, PPCM
MV,BLD& BLD 
PRODUCTS Y SELF LN HEART 12 23
88 ANJALAI 33 III 1797 G5P4L4 34 22/3/18 NO Y TACHY,HYPO ABRUPTION GRADE III BLD& BLD PRODUCTS Y PHC EMER LSCS 13 24
89 MUTHULAKSHMI 27 III 1805 G3P2L2 34 22/3/18 NO Y
GHTN,DYSPNEO
IC GHTN,ACUTE  PE MV,INJ.LASIX Y PHC LN LUNGS 13 30
90 NAGAVALLI 23 IV 1937 PRIMI 36 28/3/18 NO Y GHTN, TACHY, AP ECLAMPSIA MV ,INJ MGSO4 NO PHC LN BRAIN 11 21
91 PUSHPARANI 36 III 1987 G2P11 38 21/3/18 YES y TACHY,HYPO ATONIC  PPH BLD& BLD PRODUCTS Y PHC
EMER 
HYSTRECTOMY 9 16
92 MAHALAKSHMI 27 IV 2239 PRIMI 34 24/4/18 NO Y
GHTN,TACHY,U
NCONSICIOUS GHTN,AP ECLAMPSIA MV, NO PHC LN BRAIN 6 18
93 MOHANADEVI 22 III 2736 P1L1 PN 1/5/2018 NO Y
TACHY,HYPO,U
NCONSCIOUS GHTN,PP ECLAMPSIA MV  ,INJ.MgSO4 NO PHC EMER LSCS BRAIN 13 25
94 CHELLAMANI 32 III 31079 G4P3L3 36 17/5/18 NO Y GHTN, TACHY, ATONIC  PPH MV,BLD NO PHC
EMER 
HYSTERCTOMY 6 13
95 VANITHA 22 IV 27179 PILO PN 1/6/2018 NO Y GHTN,TACHY
ABRUPTION GRADE 
III,AP ECLAMPSIA MV,INJ MgSO4,BLD NO GH EMER LSCS BRAIN 11 27
96 PAPPATHY 27 III 44130 G3P2L2 38 11/7/2018 NO Y TACHY,HYPO ATONIC  PPH BLD& BLD PRODUCTS Y PHC
EMER 
LAPARATOMY 3 10
97 PERIYANATCHI 31 V 30319 G5P3L3 34 14/5/18 NO Y
TACHY,HYPO,P
ALLOR RUPTURE UTERUS BLD& BLD PRODUCTS Y PHC
EMER 
HYSTRECTOMY 7 14
98 KALAIMANI 22 IV 31001 PILI PN 21/5/18 NO Y
GHTN,TACHY,U
NCONSICIOUS PP ECLAMPSIA MV NO PHC EMER LSCS BRAIN 8 14
99 MAHALAKSHMI 21 III 34117 PRIMI 34 30/5/18 NO Y TACHY,HYPO ATONIC  PPH BLD & BLD PRODUCTS Y
EMER 
HYSTRECTOMY 11 17
100 MOULIYA 20 IV 65312 PRIMI 36 10/6/2018 NO Y
GHTN,TACHY,H
YPO AP ECLAMPSIA MV NO PHC LN BRAIN 9 28
101 BHUVANESHWARI 31 III 38537 G3P2L2 34 18/6/18 NO Y GHTN,TACHY ATONIC  PPH BLD& BLD PRODUCTS Y GH EMER LSCS 13 27
102 LAKSHMI 30 IV 4204 G4P3L3 30 2/7/2018 NO Y GHTN, TACHY, HELLP,AP ECLAMPSIA
BLD& BLD 
PRODUCTS,MV Y PHC EMER LSCS
BRAIN,LIVE
R 13 32
103 PADMA 29 III 5317 PRIMI 32 14/8/18 NO Y GHTN,TACHY AP ECLAMPSIA MV Y PHC
SPONTANEOUS 
EXPULSION BRAIN 5 15
104 MARIYAYEE 22 III 53464 P1L1 PN 17/8/18 NO Y GHTN,HYPO PP ECLAMPSIA MV Y PHC LN BRAIN 5 13
105 THILAGAVATHY 32 IV 56294 PRIMI 28 5/8/2018 NO Y
GHTN,HYPO,UN
CONSCIOUS
GHTN,IUD,AP 
ECLAMPSIA
MV,BLD & BLD 
PRODUCTS Y PHC EMER LSCS BRAIN 6 16
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ABBREVIATIONS 
 
MNM   - Maternal Near Miss 
SAMM  - Severe Acute  Maternal  Morbidity 
PPH   - PostPartum  Haemorrhage 
APH   - AntePartum Haemorrhage 
AP Eclampsia -  AntePartum Eclampsia 
PP Eclampsia -  Postpartum  Eclampsia 
HELLP  -  Hemolysis, Elevated Liver Enzymes Low Platelets 
ICD   -   International Classification of the Diseases 
UNICEF  -   United Nation International Children’s Education Funds 
UNPF   -  United Nation Population Fund 
WHO   - World  Health  Organisation 
 
 
  
 
MASTER CHART CODING 
D  -  Days 
H  -  Hours 
Y  -  Yes 
N  -  No 
LN  - Labour Natural 
Epi  -  Episotomy 
Bld  -  Blood 
HELLP -  Hemolysis, Elevated Liver Enzymes, Low Platelets. 
P  -  Primi 
M  -  Multi 
 
  
PROFORMA 
 
Name    : ……………………………………………… 
Age    : ………………………………………………  
Education   : ……………………………………………… 
IP No    : ……………………………………………… 
D.o. Admission  : ………………………………………………  
D.o. Delivery  : ……………………………………………… 
D.o. Near MISS  : ……………………………………………… 
D.o. Discharge   ………………………………………………  
Type of admission  : ……………………………………………… 
LMP    : ……………………………………………… 
EDD    : ……………………………………………… 
Duration of hospital stay : ……………………………………………… 
Duration of ICU stay : ……………………………………………… 
Obstetric code  : ……………………………………………… 
Gestational age  : ……………………………………………… 
Address and contact no : ……………………………………………… 
Presenting complaints : ……………………………………………… 
Menstrual history  : ……………………………………………… 
  
Marital history  : ……………………………………………… 
Obstetric history  : ……………………………………………… 
Past history    : ……………………………………………… 
General examination  : ……………………………………………… 
Height    : ……………………………………………… 
Weight    : ……………………………………………… 
Anaemia    : ……………………………………………… 
Edema    : ……………………………………………… 
Pulse Rate   : ………………………………………………  
BP     : ……………………………………………… 
CVS     : ……………………………………………… 
RS    : ……………………………………………… 
Obstetric examination : ……………………………………………… 
P/A examination  : ……………………………………………… 
P/V examination  : ……………………………………………… 
  
DIAGNOSIS 
Date and time of induction : ……………………………………………… 
Indication for induction  : ……………………………………………… 
Mode of delivery   : ……………………………………………… 
Baby weight   : ……………………………………………… 
Baby sex    : ……………………………………………… 
Apgar    : ……………………………………………… 
Puerperium    : ……………………………………………… 
Intervention    : ……………………………………………… 
 
  
CONSENT FORM  
 
I agree to participate in the study entitled “STUDY OF SAMM AT A 
TERTIARY CARE HOSPITAL AT MGMGH, KAPV GOVT MEDICAL 
COLLEGE HOSPITAL”. 
 
I confirm that I have been told about this study in my mother tongue and 
have had the opportunity to clarify my doubts. 
 
I understand that my participation is voluntary and I may refuse to 
participate at any time without giving any reasons and without affecting my 
benefits. 
 
I agree not to restrict the use of any data or results that arise for this study.  
 
 
Name of the participant  : 
Signm/ Thumb Print   : 
Name of the Investigator : Dr. A.ADHIRAI 
Sign of Investigator  :  
  
jfty; gbtk; 
 
jpUr;rpuhg;gs;sp, kfhj;kh fhe;jp epidT kUj;Jtkidapd; fpMng tpRtehjd; 
kUj;Jtfy;Yhupapy; kfg;NgW kw;Wk; ngz;fs; ey kUj;Jt Jiwapy; Nkw;nfhs;sg;gLk; Ma;T 
njhlHghd gbtk; ,J. 
 
,e;j Ma;T mDgtk; tha;e;j kUj;JtHfspd; cjtpNahL elj;jg;gLfpwJ. 
Mghafuj;jpy; ,Ue;J fhg;ghw;wg;gl;l fHgpzp ngz;fs; gw;wpa Ma;T 
 
,jdhy;, ve;jtpj gpd;tpisTfSk; NehahspfSf;F tuhJ 
 
  ,e;j Ma;T Nehahspfs; jq;fs; Ra tpUg;gj;Jld; Kd;te;jhy; kl;LNk Nkw;nfhs;sg;gLk;. 
 
  
Ra Xg;Gjy; gbtk; 
 
“mghafuj;jpy; ,Ue;J fhg;ghw;wg;gl;l fHg;gpzp ngz;fs; gw;wpa Ma;T” 
Ma;thsH 
kUj;JtH.M.Mjpiu 
KJepiy gl;l Nkw;gbg;G khztH 
kfg;NgW kw;wk; ngz;fs; eyj;Jiw 
kfhj;kh fhe;jp epidT kUj;Jtkid 
fpMng tpRtehjd; kUj;Jtfy;Yhhp 
jpUr;rpuhg;gs;sp 
 
ngaH:……………………………………taJ:…………. cs;spUg;G vz;:……………  
 
,e;j kUj;Jt Ma;tpd; tptuq;fs; vdf;F tpsf;fg;gl;lJ vd;Dila re;Njfq;fis 
jPHf;fTk; mjw;fhs jFe;j tpsf;fq;fis ngwTk; tha;g;gspf;fg;gl;lJ. 
 
 ehd; ,t;tha;tpy; jd;dpr;irahfj;jhd; gq;Nfw;fpNwd;. ve;j fhuzj;jpdhYk; ve;j 
fl;lj;jpYk; ve;j rl;lrpf;fYk; ,d;wp ,e;j Ma;tpypUe;J tpyfpf; nfhs;syhk; vd;Wk; mwpe;J 
nfhz;Nld;. 
 
ehd; Ma;tpypUe;J tpyfpf;nfhz;lhYk; Ma;thsH vd;Dila kUj;Jt mwpf;iffis 
ghh;g;gjw;Nfh my;yJ cgNahfpf;fNth vd; mDkjp Njitapy;iy vdTk; mwpe;J nfhz;Nld; 
vd;id gw;wpa jfty;fs; ufrpakhf ghJfhf;fg;gLk; vd;gijAk; mwpNtd;. 
 
,e;j Ma;tpd; %yk; fpilf;Fk; jfty;fisAk; ghpNrhjid KbTfisAk; Ma;thsH 
mtH tpUg;gj;jpw;Nfw;g gad;gLj;jpf; nfhs;sTk; mjid gpufhpf;fTk; KOkdJld; 
rk;kjpf;fpNwd;. 
 
,e;j Ma;tpy; gq;F nfhs;s xg;Gf;nfhs;fpNwd; vdf;F nfhLf;fg;gl;Ls;s mwpTiuapd;gb 
ele;J nfhs;tJld; Ma;thsUf;F cz;ikAld; ,Ug;Ngd; vd;Wk; cWjp mspf;fpNwd;. 
 
cly;eyk; ghjpf;fg;gl;lhNyh tof;fj;jpw;F khwhd VNjDk; Neha;Fwp njd;gl;lhNyh 
mjid njhptpg;Ngd; vd;Wk; cWjp $WfpNwd;. 
 
,e;j Ma;tpy; vdf;F vt;tpjkhd ghpNrhjidfisAk; rpfpr;irfisAk; Nkw;nfhs;s ehd; 
vd; KOkdJld; rk;kjpf;fpNwd;. 
 
 
 
Ma;thshpd; ifnahg;gk;    Nehahspapd; ifnahg;gk; 
